Insider · CIK 0001189154

PENDERGAST MARY K

Reports to the SEC for 2 companies · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001189154

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−16.9K sh	—	—	0
2018-05-04	Impax Laboratories, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−5,408 sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,300 sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2018-05-04	Impax Laboratories, LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2017-05-16	Impax Laboratories, LLCA Award	Director	AAward	+4,375 sh	—	—	22,350
2017-05-16	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+10.6K sh	—	—	10,575
2016-05-17	Impax Laboratories, LLCA Award	Director	AAward	+4,375 sh	—	—	17,975
2016-05-17	Impax Laboratories, LLCStock Option (Right to Buy)A Award	Director	AAward	+10.6K sh	—	—	10,575
2015-05-12	Impax Laboratories, LLCA Award	Director	AAward	+3,100 sh	—	—	13,600
2015-05-12	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+7,300 sh	—	—	7,300
2013-07-05	Impax Laboratories, LLCA Award	Director	AAward	+5,700 sh	—	—	5,700
2013-07-05	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2010-02-05	ORKAOruka Therapeutics, Inc. · Option to Purchase Common StockA Award	Director	AAward	+3,500 sh	—	—	3,500
2009-02-27	ORKAOruka Therapeutics, Inc. · Option to Purchase Common StockA Award	Director	AAward	+7,500 sh	—	—	7,500
2007-05-31	ORKAOruka Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2005-05-24	ORKAOruka Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
May 84
PENDERGAST MARY K0001003642-18-000087
SEC(opens sec.gov)
May 174
IMPAX LABORATORIES INC0001003642-17-000053
SEC(opens sec.gov)
May 194
IMPAX LABORATORIES INC0001437749-16-032320
SEC(opens sec.gov)
May 134
IMPAX LABORATORIES INC0001437749-15-010005
SEC(opens sec.gov)
Jul 94
IMPAX LABORATORIES INC0001437749-13-008586
SEC(opens sec.gov)
Feb 94
PENDERGAST MARY K0001181431-10-007736
SEC(opens sec.gov)
Mar 34
PENDERGAST MARY K0001123292-09-000264
SEC(opens sec.gov)
Jun 14
NUVELO INC0000907654-07-000006
SEC(opens sec.gov)
May 264
NUVELO INC0000907654-05-000022
SEC(opens sec.gov)

Companies

Address

C/O PENDERGAST CONSULTING 4328 YUMA ST. NW

WASHINGTON, DC, 20016